Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page
- Check4 days agoChange DetectedThe page’s revision entry was updated from v3.6.3 to v3.6.4 in the record history, indicating a new version of the page has been stored for the study record. This reflects an internal update to the page rather than changes to study data or descriptions.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated to v3.6.3 in the page history, indicating a platform update rather than changes to study data.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history now shows a new revision label v3.6.2, replacing the previous v3.6.0. This reflects an update to the page revision rather than to study data.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, and the record has been updated to revision v3.6.0, with the previous revision v3.5.5 removed.SummaryDifference0.3%

- Check54 days agoChange DetectedA new revision (v3.5.5) was added to the history and the previous revision (v3.5.4) was removed, updating the study record history on ClinicalTrials.gov.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.5.4 was added to the study record history, while the previous revision v3.5.3 was removed from the visible list, reflecting an update to the record's version history.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.